Synertech PM (United States)

Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-α2a) plus an anthracycline-based induction regimen

R V Smalley, Edie Weller, MJ Hawkins et al. · Leukemia · 2001 · 32 citations

Lymphoid Neoplasia, Health Sciences, Medicine +12

Chemoenzymatic Synthesis of 5‐Thio‐<scp>D</scp>‐xylopyranose

Franck Charmantray, Philippe Dellis, Virgil Hélaine et al. · European Journal of Organic Chemistry · 2006 · 29 citations · Full text

Chemoenzymatic Synthesis, Medicinal Chemistry, Biosynthesis +14

DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events.

David J. Speicher, Jessica Rose, L. Maria Gutschi et al. · 2023 · 17 citations · Full text

Immunology, Escherichia Coli, Bivalent Pfizer/biontech +19

Modification of surface characteristics in GaAs with dry processing

Yao-An Chung, D. W. Langer, Ralf Becker et al. · IEEE Transactions on Electron Devices · 1985 · 17 citations

Optical Materials, Engineering, Optoelectronic Devices +17

Oral piritrexim — A phase II study in patients with advanced soft tissue sarcoma

Judith D. Schiesel, Matthew Carabasi, Gordon B. Magill et al. · Investigational New Drugs · 1992 · 14 citations

Medicine, Oral Medicine, Pathology +1